arctigenin has been researched along with Acute Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, X; Cheng, Y; Da, Y; Li, Y; Wang, D; Wang, H; Wang, Y; Xue, Z; Yang, F; Yang, J; Yang, L; Zhang, L; Zhang, Q; Zhang, R; Zhou, D | 1 |
1 other study(ies) available for arctigenin and Acute Disease
| Article | Year |
|---|---|
Arctigenin protects against liver injury from acute hepatitis by suppressing immune cells in mice.
Topics: Acute Disease; Animals; CD4-Positive T-Lymphocytes; Concanavalin A; Furans; Hepatitis; Inflammation; Inflammation Mediators; Interleukin-10; Lignans; Liver; Macrophages; Male; Mice; Mice, Inbred BALB C; Natural Killer T-Cells; Protective Agents; RAW 264.7 Cells | 2018 |